These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 7521834)

  • 1. Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.
    Brogden RN; Fitton A
    Drugs; 1994 Jun; 47(6):983-1009. PubMed ID: 7521834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS.
    Cohn DL
    Drugs; 1997; 54 Suppl 2():8-15; discussion 28-9. PubMed ID: 9358195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifabutin prophylaxis for Mycobacterium avium complex infection in patients with AIDS.
    Siegal FP
    Clin Infect Dis; 1996 Apr; 22 Suppl 1():S23-30; discussion S30-2. PubMed ID: 8785252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifabutin: a review with emphasis on its role in the prevention of disseminated Mycobacterium avium complex infection.
    Maddix DS; Tallian KB; Mead PS
    Ann Pharmacother; 1994 Nov; 28(11):1250-4. PubMed ID: 7849340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of rifabutin in the treatment of disseminated infection due to Mycobacterium avium complex. The Rifabutin Treatment Group.
    Sullam PM; Gordin FM; Wynne BA
    Clin Infect Dis; 1994 Jul; 19(1):84-6. PubMed ID: 7948562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with rifabutin in the treatment of mycobacterial infections.
    De Cian W; Sassella D; Wynne BA
    Scand J Infect Dis Suppl; 1995; 98():22-6. PubMed ID: 8867175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterium avium complex infection. Pharmacokinetic and pharmacodynamic considerations that may improve clinical outcomes.
    Peloquin CA
    Clin Pharmacokinet; 1997 Feb; 32(2):132-44. PubMed ID: 9068928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifabutin for MAC questioned.
    Posit Aware; 1995; ():6. PubMed ID: 11362571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated Mycobacterium avium complex disease in patients with AIDS.
    Benson C
    AIDS Res Hum Retroviruses; 1994 Aug; 10(8):913-6. PubMed ID: 7811542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Researchers find new drugs to fight MAC.
    AIDS Alert; 1995 Nov; 10(11):138-9. PubMed ID: 11362925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group.
    Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM
    N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium avium complex infection, rifabutin, and uveitis--is there a connection?
    Nichols CW
    Clin Infect Dis; 1996 Apr; 22 Suppl 1():S43-7; discussion S47-9. PubMed ID: 8785256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team.
    Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R
    J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early bactericidal activity of rifabutin versus that of placebo in treatment of disseminated Mycobacterium avium complex bacteremia in AIDS patients.
    Dautzenberg B; Castellani P; Pellegrin JL; Vittecoq D; Truffot-Pernot C; Pirotta N; Sassella D
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1722-5. PubMed ID: 8807071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis of Mycobacterium avium complex bacteremia in patients with AIDS.
    Gordin F; Masur H
    Clin Infect Dis; 1994 Apr; 18 Suppl 3():S223-6. PubMed ID: 8204774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimycobacterial synergism of clarithromycin and rifabutin.
    Ghebremichael S; Svenson SB; Källenius G; Hoffner SE
    Scand J Infect Dis; 1996; 28(4):387-90. PubMed ID: 8893404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New trends in the drug therapy of localized and disseminated Mycobacterium avium complex infection.
    Sesin GP; Manzi SF; Pacheco R
    Am J Health Syst Pharm; 1996 Nov; 53(21):2585-90. PubMed ID: 8913387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical pharmacokinetics of rifabutin.
    Skinner MH; Blaschke TF
    Clin Pharmacokinet; 1995 Feb; 28(2):115-25. PubMed ID: 7736687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A fast-growing cold skin abscess revealing disseminated Mycobacterium intracellulare infection in an HIV-infected patient.
    Mendes-Bastos P; Brás S; Carvalho R
    Int J STD AIDS; 2018 Jun; 29(7):720-722. PubMed ID: 29256823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk-benefit assessment of therapies for Mycobacterium avium complex infections.
    Griffith DE
    Drug Saf; 1999 Aug; 21(2):137-52. PubMed ID: 10456381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.